3 completed, 3 unknown, 1 recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Mason-Type Diabetes: new trials by email Literature Review of Mason-Type Diabetes trials Research Report on Mason-Type Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identifying Maturity-onset Diabetes of the Young in Emirati Patients Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B) - Maturity-onset Diabetes of the Young, Monogenic Diabetes | Not applicable | Unknown | United Arab Emirates University | 150 | 2024-03-01 | 2024-01-11 |
| Optimized Diagnosis and Precision Medicine of MODY Maturity-Onset Diabetes of the Young (MODY), Type 2 Diabetes | Recruiting | Taichung Veterans General Hospital | 1500 | 2023-05-22 | 2023-11-01 | |
| Genetic Causes of Gestational Diabetes in the Emirati Population Next generation sequencing (NGS) - Gestational Diabetes, GDM | Unknown | Imperial College London Diabetes Centre | 600 | 2017-01-01 | 2020-06-25 | |
| Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes insulin therapy - Maturity-Onset Diabetes of the Young | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 46 | 2016-04-25 | 2026-03-27 |
| Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE Next generation sequencing (NGS) - Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Unknown | Imperial College London Diabetes Centre | 778 | 2015-04-01 | 2020-08-19 | |
| The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) liraglutide, Glimepiride - Maturity-onset Diabetes of the Young | Phase 2 / Phase 3 | Completed | University Hospital, Gentofte, Copenhagen | 15 | 2012-08-01 | 2013-09-05 |
| Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY) Oral Glucose Tolerance Test (OGTT), iso glycaemic intravenous (iv) glucose infusion (IIGI), Meal test - Maturity-onset Diabetes of the Young | Completed | University Hospital, Gentofte, Copenhagen | 31 | 2011-01-01 | 2013-01-15 |
Diabetes Mellitus, Type 2 (6) · Diabetes Mellitus (3) · Diabetes, Gestational (2) · Diabetes Complications (1) · Diabetes Mellitus, Type 1 (1) · Disease (1) · Maturity-Onset Diabetes of the Young, Type 2 (1) · Maturity-Onset Diabetes of the Young, Type 3 (1)
Endocrine System Diseases (7) · Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Diabetes Mellitus (4) · Female Urogenital Diseases and Pregnancy Complications (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Autoimmune Diseases (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
High-Throughput Nucleotide Sequencing (2) · Convulsive Therapy (1) · Genetic Testing (1) · Glucose Tolerance Test (1) · Liraglutide (1) · Sitagliptin Phosphate (1) · glimepiride (1)
Imperial College London Diabetes Centre (2) · University Hospital, Gentofte, Copenhagen (2) · Assistance Publique - Hôpitaux de Paris (1) · Taichung Veterans General Hospital (1) · United Arab Emirates University (1)
Denmark (2) · United Arab Emirates (2) · France (1) · Taiwan (1)
Adnan Agha (1) · Maha Barakat, PhD FRCP (1) · Nader Lessan, MBBS FRCP MD (1) · Torben Hansen, MD PhD (1) · Yi-Jing Sheen, MD. PHD (1)